Latest Pulmonology News
Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectiveness
posted October 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
HealthDay Reports: US Government Says COVID-19 Antibody Tests Must Be Free
Neutralizing Antibody Shows Potential for Mild-to-Moderate COVID-19
posted October 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
About 17 Percent of Recovered Patients Positive for SARS-CoV-2
posted October 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Parts of the World Seeing New COVID-19 Variant 
HHS, NIH Unveil Vaccine Initiative to Protect Against Future Pandemics 
Hospital-Onset SARS-CoV-2 Infection During Omicron Linked to Morbidity Related Articles
Air Pollution Does Not Impair Benefits of Walking in Reducing COPD Exacerbation Rate 
Financial Incentives Boost Tobacco Abstinence in Underserved Adults 
9 of 10 Leading Causes of Death Unchanged From 2023 to 2024 
Past Blast Exposure Tied to Long-Term Chronic Medical Diagnoses in Veterans Pulmonology Conference Highlights
Pulmonology Monthly Briefings
Pulmonology Conference News
Stay Connected
